1. Collin, J, Ralston, R, Hill, S. Signalling Virtue, Promoting Harm: Unhealthy Commodity Industries and COVID-19. NCD Alliance/SPECTRUM; 2020. https://ncdalliance.org/sites/default/files/resource_files/Signalling%20Virtue%2C%20Promoting%20Harm_Sept2020_FINALv.pdf
Google Scholar2. Paidchadze, N, Werbick, M, Ndebele, P, Bari, I, Hyder, A. Commercial determinants of health: a proposed research agenda. Int J Public Health. 2020;65:1147–1149. https://link.springer.com/article/10.1007/s00038-020-01445-9
Google Scholar | Crossref | Medline3. Hynan, A, Werbick, M, Ndebele, P, Paidchadze, N. Commercial determinants of health in COVID-19. Think Global Health. 2020; June 17. https://www.thinkglobalhealth.org/article/commercial-determinants-health-covid-19
Google Scholar4. Rochford, C, Tenneti, N, Moodie, R. Reframing the impact of business on health: the interface of corporate, commercial, political and social determinants of health. BMJ Global Health. 2019;4(4): e001510. doi:10.1136/bmjgh-2019-001510
Google Scholar | Crossref | Medline5. Parra, D, de Sa, TH, Montiero, C, Freudenberg, N. Automobile, construction and entertainment business sector influences on sedentary lifestyles. Health Promot Int. 2018;33:239–249. doi:10.1093/heapro/daw073
Google Scholar | Medline6. de Lacy-Vawdon, C, Livingstone, C. Defining the commercial determinants of health: a systematic review. BMC Public Health. 2020;20:Article 1022. doi:10.1186/s12889-020-09126-1
Google Scholar | Crossref | Medline7. Knai, C, Petticrew, M, Mays, N, et al. Systems thinking as a framework for analyzing the commercial determinants of health. Milbank Quarterly. 2020;96(3):472–498. doi:10.1111/1468-0009.12339
Google Scholar | Crossref8. Mialon, M . An overview of the commercial determinants of health. Global Health. 2020;16:74. doi:10.1186/s12992-020-00607-x
Google Scholar | Crossref | Medline9. Freudenberg, N, Lee, K, Buse, K,. et al. Defining priorities for research and action on the commercial determinants of health: a conceptual review. Am J Public Health. (2021; Oct 18. Epub ahead of print, 18 October 2021).
Google Scholar10. Flynn, M . Global capitalism as a societal determinant of health: a conceptual framework. Soc Sci Med. 2021;268:113530. doi:10.1016/j.socscimed.2020.113530
Google Scholar | Crossref | Medline11. Lacy-Nichols, J, Marten, R. Power and the commercial determinants of health: ideas for a research agenda. BMJ Global Health. 2021;6:e003850. doi:10.1136/bmjgh-2020-003850
Google Scholar | Crossref | Medline12. Friel, S . Redressing the corporate cultivation of consumption: releasing the weapon of the structurally weak. Int J Health Policy Manag. 2020; Oct 27. doi:10.34172/ijhpm.2020.205. Epub ahead of print. PMID: 33131225.
Google Scholar | Crossref13. Lee, K, Freudenberg, N. Addressing the commercial determinants of health begins with clearer definition and measurement. Glob Health Promot. 2020;27(2):3–5. doi:10.1177/1757975920931249
Google Scholar | SAGE Journals | ISI14. Mathers, C . Global burden of disease – an overview. In: Cockerham, W , ed. International Encyclopedia of Public Health, 2nd ed. Elsevier; 2017, 256–267.
Google Scholar | Crossref15. WHO . About the Global Burden of Disease (GBD) Project. 2020. https://www.who.int/healthinfo/global_burden_disease/about/en/
Google Scholar16. WHO . Global Health Risks, Mortality and burden of disease attributable to selected major risks. Geneva, 2009. https://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf
Google Scholar17. Murray, C, Lopez, A. The Global Burden of Disease, Summary. World Bank and World Health Organization Harvard University Press; 1993. https://apps.who.int/iris/bitstream/handle/10665/41864/0965546608_eng.pdf;jsessionid=9B7ECE2C86AE28FAC9475C63EAE12C5D?sequence=1
Google Scholar18. IHME . Global Burden of Disease Risk Factor Summaries. n.d. http://www.healthdata.org/results/gbd_summaries/2019/about-risk-factor-summaries
Google Scholar19. Murray, C, Aravkin, A, Zheng, P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis of the global burden of disease study 2019. Lancet. 2020;396(10298):1223–1249. doi:10.1016/S0140-6736(20)30752-2
Google Scholar | Crossref | Medline20. Van der Maas, P . Editorial: how summary measures of population health are affecting health agendas. Bull W H O. 2003;81(5):314. https://www.who.int/bulletin/volumes/81/5/vandermaas0503.pdf
Google Scholar | Medline21. Benziger, C, Roth, G, Moran, A. The global burden of disease study and the preventable burden of NCD. Glob Heart. 2016;11(4):393–397. doi:10.1016/j.gheart.2016.10.024
Google Scholar | Crossref | Medline22. WHO . Noncommunicable diseases. Fact Sheets, Geneva, 1 June 2018. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Google Scholar23. WHO . Think piece: Why is 2018 a strategically important year for NCDs? WHO Independent High-Level Commission on NCDs, Geneva, 2018. https://www.who.int/ncds/governance/high-level-commission/why-2018-important-year-for-NCDs.pdf
Google Scholar24. Baum, F, Fisher, M. Why behavioural health promotion endures despite its failure to reduce health inequities. Sociol Health Illn. 2014;36(2):213–225. doi:10.1111/1467-9566.12112
Google Scholar | Crossref | Medline25. WHO . Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. World Health Assembly, 66th Session, WHA66.10, 27 May 2013. https://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R10-en.pdf?ua=1
Google Scholar26. Horton, R . Comment: NCDs – why are we failing? Lancet 2017;390(10092):P346. doi:10.1016/S0140-6736(17)31919-0
Google Scholar | Crossref | Medline27. Krieger, N. Proximal, distal and the politics of causation: what’s level got to do with it? Am J Public Health. 2008;98(2):221–230. doi:10.2105/AJPH.2007.111278
Google Scholar | Crossref | Medline | ISI28. Maani, N, Collin, J, Friel, S, et al. Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks. Eur J Public Health. 2020;30(4):660–664. doi:10.1093/eurpub/ckz197
Google Scholar | Crossref | Medline29. Lee, K, Crosbie, E. Understanding structure and agency as commercial determinants of health. Int J Health Policy Manag 2019;9(7):315–318. doi:10.15171/IJHPM.2019.127
Google Scholar | Crossref30. Schwandt, T . Agency (vs. structure). In: The SAGE Dictionary of Qualitative Inquiry, 3rd ed. Sage; 2007, p. 5. doi:10.4135/9781412986281
Google Scholar | Crossref31. Freudenberg, N . The manufacture of lifestyle: the role of corporations in unhealthy living. J Public Health Policy. 2012;33(2):1–13. doi:10.1057/jphp.2011.60
Google Scholar | Crossref | Medline32. Henisz, W, Zelner, B. Non-market strategy. In: Augier, M, Teece, D, eds. Palgrave Encyclopedia of Strategic Management. Palgrave Macmillan; 2018 pp. 1134–1141. doi:10.1057/978-1-137-00772-8_555
Google Scholar | Crossref33. Maduriera Lima, J, Galea, S. Corporate practices and health: a framework and mechanisms. Global Health. 2018;14:Article 21. doi:10.1186/s12992-018-0336-y
Google Scholar34. Yang, J, Mamudu, H, John, R. Incorporating a structural approach to reducing the burden of non-communicable disease. Global Health. 2018;14:Article 66. doi:10.1186/s12992-018-0380-7
Google Scholar35. Crammond, B, Carey, G. What do we mean by ‘structure’ when we talk about structural influences on the social determinants of health inequalities? Soc Theory Health. 2017;15:84–98. doi:10.1057/s41285-016-0020-3
Google Scholar | Crossref36. Walls, H, Peeters, A, Loff, B, Crammond, B. Editorial: why education and choice won’t solve the obesity problem. Am J Public Health. 2009;99(4):590–591. doi:10.2105/AJPH.2008.156232
Google Scholar | Crossref | Medline37. Spiro, M . A typology of social structure and the patterning of social institutions: a cross-cultural study. Am Anthropol. 1965;67:1097–1119. https://anthrosource.onlinelibrary.wiley.com/doi/pdf/10.1525/aa.1965.67.5.02a00010
Google Scholar | Crossref38. Layder, D . Linking agency and structure and macro and micro. In: Understanding Social Theory, 2nd ed. Sage; 2006:193–212.
Google Scholar | Crossref39. Williams, G . The determinants of health: structure, context and agency. Sociol Health Illn. 2003;25:131–154. https://onlinelibrary.wiley.com/doi/pdf/10.1111/1467-9566.00344
Google Scholar | Crossref | Medline | ISI40. Hay, C . Beyond structure versus agency, conduct versus context. In: Political Analysis, A Critical Introduction. Springer; 2002:89–134.
Google Scholar | Crossref41. Wood, B, Williams, O, Nagarajan, V, Sacks, G. Market strategies used by processed food manufacturers to increase and consolidate their power: a systematic review and document analysis. Global Health. 2021;17:Article 17. doi:10.1186/s12992-021-00667-7
Google Scholar42. MacKenzie, R, Lee, K, LeGresley, E. To ‘enable our legal product to compete effectively with the transit market’: British American tobacco’s strategies in Thailand following the 1990 GATT dispute. Glob Public Health. 2015;11(3):348–362.
Google Scholar | Crossref | Medline43. Holden, C, Lee, K. ‘A major lobbying effort to change and unify the excise structure in six central American countries’: how British American tobacco influenced tax and tariff rates in the central American common market. Global Health. 2011;7(1):e15. doi:10.1186/1744-8603-7-15
Google Scholar | Crossref | Medline44. Haar, K . Cooperating to deregulate. Corporate Europe Observatory, September 2015. http://www2.euromemorandum.eu/uploads/haar_ttip_regulatory_cooperation_and_better_regulation.pdf
Google Scholar45. Lee, K, Eckhardt, J, Holden, C. Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda. Palgrave Commun 2016;2:Article 16037. doi:10.1057/palcomms.2016.37
Google Scholar | Crossref | Medline46. Schiff, H, Bass, R, Cohen, R. The Business Value of Impact Measurement. Global Impact Investing Network Issue Brief, August 2016. https://thegiin.org/assets/GIIN_ImpactMeasurementReport_webfile.pdf
Google Scholar47. OECD . Measuring Business Impacts on People’s Well-being and Sustainability. https://www.oecd.org/investment/measuring-business-impacts-on-peoples-well-being.htm
Google Scholar48. Evans, R, Lloyd, P. Measuring the business value of corporate social impact: Beyond social value to enterprise performance. Deloitte Insights, 27 July 2020. https://www2.deloitte.com/content/dam/insights/us/articles/6737_measuring-business-value/DI_DR27-Measuring-corporate-impact.pdf
Google Scholar49. Baum, F, Sanders, D, Fisher, M, et al. Assessing the health impact of transnational corporations: its importance and a framework. Global Health. 2016;12:Article 27. doi:10.1186/s12992-016-0164-x
Google Scholar | Medline50. Lima, JM, Galea, S. The corporate permeation index – a tool to study the macrosocial determinants of non-communicable disease. SSM Population Health 2019;7:100361. doi:10.1016/j.ssmph.2019.100361
Google Scholar | Crossref | Medline51. Bakan, J . The Corporation, The Pathological Pursuit of Profit and Power. Penguin; 2004.
Google Scholar52. Baum, F, Anaf, J, Fisher, M. Corporate health impact assessment of a fast food company: implications for NCDs. In: Post presentation, Prince Mahidol Annual Conference, Bangkok, 2019. https://pmac2019.com/uploads/poster/A092-FRANBAUM-7874.pdf
Google Scholar53. Yang, J, Mamudu, H, John, R. Incorporating a structural approach to reducing the burden from non-communicable diseases. Global Health. 2018;14:Article 66. doi:10.1186/s12992-018-0380-7
Google Scholar54. UK House of Commons . Registrar of Consultant Lobbyists, Statement of Accounts (for the year ended 31 March 2020). HMSO. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/902761/ORCL-2019-20-Annual-Report-Accounts-laid.pdf
Google Scholar55. Transparency International UK . For lobbying in the UK, it’s time for a change. 13 October 2015. https://www.transparency.org.uk/lobbying-uk-its-time-change
Google Scholar56. European Commission . Cost of Non-communicable diseases in the EU. Health Promotion and Disease Prevention Knowledge Gateway, 2019. https://ec.europa.eu/jrc/en/health-knowledge-gateway/societal-impacts/costs
Google Scholar57. Bollyky, T, Templin, T, Cohen, M, Deileman, J. Lower-income countries that face the most rapid shift In noncommunicable disease burden are also the least prepared. Health Aff. 2017;36(11). doi:10.1377/hlthaff.2017.0708
Google Scholar | Crossref58. Sheldon, T . Twin epidemics of covid-19 and non-communicable disease. Br Med J. 2020;369:m2618. doi:10.1136/bmj.m2618
Google Scholar